AViTA Corporation (4735) - Cash Flow Conversion Efficiency
Based on the latest financial reports, AViTA Corporation (4735) has a cash flow conversion efficiency ratio of 0.043x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$42.34 Million ≈ $1.33 Million USD) by net assets (NT$996.01 Million ≈ $31.38 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of AViTA Corporation to measure how many days the company can operate on defensive assets alone.
AViTA Corporation - Cash Flow Conversion Efficiency Trend (2017–2025)
This chart illustrates how AViTA Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data.
AViTA Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of AViTA Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SBF AG
F:CY1K
|
N/A |
|
Youil Energy Technology Co. Ltd.
KQ:340930
|
-0.002x |
|
JERSEY OIL+GAS PLC LS-01
F:TPC1
|
N/A |
|
Cellumed Co. Ltd
KQ:049180
|
-0.018x |
|
Stablecoin Development Corporation
NYSE MKT:SDEV
|
0.100x |
|
P&K Skin Research Center Co. Ltd
KQ:347740
|
0.021x |
|
Estrella Resources Ltd
AU:ESR
|
-0.064x |
|
Apex Equity Holdings Bhd
KLSE:5088
|
-0.044x |
Annual Cash Flow Conversion Efficiency for AViTA Corporation (2017–2025)
The table below shows the annual cash flow conversion efficiency of AViTA Corporation from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see AViTA Corporation stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | NT$996.01 Million ≈ $31.38 Million |
NT$64.46 Million ≈ $2.03 Million |
0.065x | -71.83% |
| 2024-12-31 | NT$838.11 Million ≈ $26.41 Million |
NT$192.52 Million ≈ $6.07 Million |
0.230x | -3.76% |
| 2023-12-31 | NT$888.28 Million ≈ $27.99 Million |
NT$212.02 Million ≈ $6.68 Million |
0.239x | -55.66% |
| 2022-12-31 | NT$911.18 Million ≈ $28.71 Million |
NT$490.50 Million ≈ $15.45 Million |
0.538x | +116.24% |
| 2021-12-31 | NT$952.03 Million ≈ $29.99 Million |
NT$237.01 Million ≈ $7.47 Million |
0.249x | -44.28% |
| 2020-12-31 | NT$909.43 Million ≈ $28.65 Million |
NT$406.31 Million ≈ $12.80 Million |
0.447x | +1.28% |
| 2019-12-31 | NT$525.49 Million ≈ $16.56 Million |
NT$231.81 Million ≈ $7.30 Million |
0.441x | +73.06% |
| 2018-12-31 | NT$422.85 Million ≈ $13.32 Million |
NT$107.78 Million ≈ $3.40 Million |
0.255x | -29.33% |
| 2017-12-31 | NT$445.11 Million ≈ $14.02 Million |
NT$160.55 Million ≈ $5.06 Million |
0.361x | -- |
About AViTA Corporation
AViTA Corporation engages in the research, development, manufacturing, and sales of home healthcare products. Its products include non-contact thermometer, infrared ear/forehead thermometer, infrared ear thermometer, wrist type blood pressure monitor, arm type blood pressure monitor, nasal aspirator, nebulizer, electronic breast pump, pulse oximeter, and electronic lice comb. AViTA Corporation wa… Read more